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Abstract Metabolic effects of delta-sleep inducing peptide 
(DSIP) under hypoxia stress were investigated in rats subjected 
to short-term hypoxic conditions (about 0.26 Bar). It was found 
that DSIP partially restricted stress-induced changes in activity 
of mitochondrial monoamine oxidase type A (MAO-A) and sero- 
tonin level in rat brain. A number of DSIP analogues was tested 
and among them there were some compounds with enhanced 
ability to counteract hypoxia induced changes in MAO-A activity 
and serotonin content in comparison with native neuropeptide. 
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I. Introduction 
Humoral sleep factor DSIP (delta-sleep inducing peptide) 
was isolated from cerebral venous blood of rabbits and its 
structure was determined by Swiss research group (M. Monnier 
and G. Schoenenberger, 1977). This linear endogenous nona- 
peptide received the name delta-sleep inducing peptide due to 
its ability to increase EEG slow wave sleep (or delta-sleep) in
rabbits [1]. Somnogenic activity of synthetic DSIP was reported 
in a number of papers in various animal species and in human 
but some other publications did not confirm somnogenic prop- 
erties (for a review see [2]). Although Swiss authors consider 
DSIP as a natural regulator of sleep-waking function [2] hypno- 
genic action of DSIP still remains doubtful. 
DSIP has a number of other nonspecific for sleep effects [3]. 
According to our data the most pronounced feature of its 
multifunctional physiological action is the highly expressed 
stress-protective and adaptogenic activity. Thus, DSIP after 
peripheral administration in a small dose (100-200 ¢tg/kg) sig- 
nificantly increases resistance of animals to acute emotional 
stress by prevention of cardiovascular disturbances [4,5], en- 
hances adaptation to cold by normalization of cold-induced 
biochemical shifts [6,7], prevents metabolic hanges in brain 
under experimental hypoxia [8], inhibits metastatic spreading 
and remarkably increases the stability of organism to tumour 
growth due to restoration of neurohumoral indices and the 
immunomodulating potency of the host [9,10]. DSIP has also 
well documented antiepileptic activity under experimental p- 
plication of different seizure inducing agents [11]. A number of 
DSIP analogues was synthesized and their antiepileptic and 
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antimetastatic potency were investigated in some test-models 
along with DSIR Certain structure activity dependences were 
established for this series of compounds [9,12]. 
2. Materials and methods 
The experiments were carried out on white not throughbred male rats 
(180-200 g). Hypoxia stress was modelled by pressure chamber under 
0.26 Bar (that corresponds to altitude of 10 km above the ground level) 
during 15 rain. Peptides were dissolved in saline and injected intraper- 
itoneally in a dose of 120,ug/kg 20 min prior to stressfull manipulations. 
The mitochondria and cytoplasmic fractions were isolated from rat 
brain as described in[13]. Mitochondria were then purified by differen- 
tial centrifugation in the gradient of saccharose d nsity (0.32; 0.80 and 
1.2 M). Monoamine oxidase activity was determined by means of iso- 
thermic ammonia evaporation using saturable concentration f sero- 
tonin as substrate by modified Gorkin method [14]. The content of 
serotonin in rat brain was measured by procedure described in [15]. 
DSIP and analogues were synthesized asdescribed in[12] by solid- 
phase method on the 9500 Peptide Synthesizer (MiliGen/Biosearch). 
Final products were obtained by gel-filtration on Sephadex G-15 or 
preparative RP HPLC, the content of desirable substances was more 
than 97%. The purity and individuality of the peptides was controlled 
by HPLC, FAB-mass pectrometry, NMR-spectroscopy and amino 
acid analysis. 
For data analysis, Student's t-test was used. 
3. Results and discussion 
Changes in enzyme activity are a key mechanism for regula- 
tion of metabolic processes under alterations in functional state 
of an organism. Monoamine oxidase (MAO) is known as an 
important brain enzyme participating in metabolism of bio- 
genic monoamines. It determines significantly their level in the 
brain and thereby provides a control of their neurotransmitter 
and hormonal functions. MAO ranks among membrane n- 
zymes and is located essentially on the exterior membrane of 
mitochondria. Its activity depends on a lipid environment. The 
regulative role of membrane lipids upon properties of MAO 
was established [16,17]. There are two types of MAO in brain 
and other tissues: MAO-A and MAO-B. MAO-A has its own 
specific substrates of oxidation: serotonin and noradrenaline. 
This enzyme is contained essentially in monoaminoergic neu- 
rons and acts intraneuronally while MAO-B has extraneuronal 
localization in glial cells [16]. 
Investigation of MAO activity in brain of rats subjected to 
action of stressful stimuli revealed significant changes in its 
activity in the case of cranium-brain trauma [18], hyperoxia [19] 
and barometric hypoxia [8]. Earlier Krichevskaya etal. [7] have 
shown that cold housing of rats causes remarkable changes in 
substrate specificity of brain MAO-A: it becomes capable of 
desaminating unusual substrates such as glucosamine. Prelimi- 
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Fig. 1. (A) Activity of MAO-A in mitochondrial fractions from brain 
of the following groups of rats: (1) intact (open bars); (2) subjected to 
hypoxia (filled bars); (3) pretreated with tested peptides (120,ug/kg, i.p.) 
before hypoxia stress (hatched bars). (B) Concentration f serotonin i  
brain of rats from the same groups. Experiments for analogues were 
done separately throughout a period of several months and this may 
be a reason of remarkable deviations in initial MAO-A activity and 
serotonin content in brain of rats under hypoxia. Results are expressed 
as means + S.E.M. for each group of animals (n = 6 8). 
nary injection of DSIP (i.p., 120 ¢tg/kg) into rats subjected to 
cold mitigated stress-induced changes in activity of this enzyme. 
Therefore in present study we assessed the influence of DSIP 
and its analogues on the activity of mitochondrial MAO type 
A and the level of its substrate serotonin in rat brain under 
experimental hypoxia. In accordance with the data, presented 
in the Table MAO-A exhibited the activity only in mitochon- 
drial fraction and this activity was practically not found in 
cytoplasmic fraction obtained from the brain of intact animals. 
Injection of DSIP to intact rats did not significantly influence 
MAO-A activity in the brain. Subjection of rats to hypoxia 
conditions leads to decrease of MAO-A activity in mitochon- 
dria and its adventing in cytoplasme. Preliminary injection of 
DSIP (i.p., 120 ¢tg/kg) to rats before stressful shortterm housing 
in reduced atmosphere partially inhibited hypoxia induced 
changes. Mitochondrial MAO-A activity was increased about 
46% in comparison with DSIP-untreated rats under hypoxia 
although it did not reach the values corresponding to intact 
animals. At the same time the opposite effect of DSIP on 
MAO-A activity in cytoplasme may be traced. In addition 
DSIP has a tendency to normalize the serotonin content in 
brain of rats under hypoxia (Table I). All these effects caused 
by DSIP under hypoxia are not fully significant but they may 
be considered as a definite tendency of this peptide to mitigate 
stress-induced changes in MAO-A activity. 
It seems reasonable to say that decrease of MAO-A activity 
in mitochondria may be connected with activation of lipid per- 
oxidation as a key event caused by stressful stimuli. Changing 
lipid environment may influence the MAO-A activity. The first 
evidence implies that association of the enzyme with outer 
mitochondrial membrane is disrupted. This event is followed 
by MAO-A release to the cytoplasme. Preventive ffect of DSIP 
might be attributed to ability of this peptide to decrease the 
intensity of lipid membrane peroxidation [20] and thereby to 
retain the association of enzyme with mitochondrial mem- 
branes. 
Thus, we may conclude that DSIP partially restricted hy- 
poxia-induced changes in MAO-A activity of brain and these 
effects are in a good agreement with the ability of this peptide 
to retard undesirable metabolic deviations under stressful con- 
ditions mentioned above. 
In order to shed more light to relationships between structure 
and biological activity we investigated the related effects of 
DSIP analogues in comparison with aforementioned action of 
DSIP in rats under hypoxia. Therefore a number of DSIP 
analogues varying in positions 1, 2 and 6 were tested: 
1 2 3 4 5 6 7 8 9 
DSIP Trp-Ala- - -Gly- -Gly- -Asp- -A la- -Ser- -Gly- -Glu 
ID-I Trp-DVal - -Gly- -Gly- -Asp- -A la- -Ser- -Gly- -Glu 
ID-3 T rp -DA la - -G ly - -G ly - -Asp- -~r - -Ser - -G ly - -G lu  
ID-4 Trp-DLeu--Gly- -Gly- -Asp- -A la- -Ser- -Gly- -Glu 
ID-5 T~r~-Pro---Gly--Gly--Asp--Ala--Ser--Gly--Glu 
ID-8 ~r -DA la - -G ly - -G ly - -Asp- -A la - -Ser - -G ly - -G lu  
ID-13 Trp-DPhe--Gly- -Gly- -Asp- -A la- -Ser- -Gly- -Glu 
To compare efficiency of these analogues we analyzed the 
changes in activity of mitochondrial MAO-A and also in the 
content of serotonin in rat brain after their injection before 
hypoxia manipulation (Fig. 1A,B). The data obtained we com- 
pared with corresponding values for rats subjected to hypoxia 
without preliminary injection of analogues. We found ana- 
logues ID-3 and ID-5 much more active than DSIR They 
almost fully prevented stress-induced changes in mitochondrial 
Table 1 
Influence of DSIP pretreatment (120/lg/kg, i.p.) on serotonin content 
and distribution of MAO-A activity between mitochondrial nd cyto- 
plasmic fractions from rat brain under hypoxia stress 
Group of Activity of MAO-A (nmol The content of se- 
animals NH]mg protein/min) rotonin in rat 
brain 
Mitochondrial Cytoplasmic (flg/kg tissue) 
fraction fraction 
Intact 1.96 + 0.28 nd 0.92 + 0.08 
(n = 5) (n = 13) 
Pretreated with 2.48 + 0.26 nd 1.00 + 0.04 
DSIP (n = 4) (n = 6) 
Subjected to 0.91 + 0.13 1.15 + 0.37 1.35 _+ 0.30 
hypoxia (n = 6) (n = 6) t,2 = 6) 
Subjected to 
hypoxia and 1.33 + 0.28 0.70 _+ 0.32 1.06 + 0.25 
pretreated (n = 7) (n = 7) (n = 6) 
with DSIP 
Values represent mean _+ S.E.M, The number of animals is given in 
parentheses; nd, not detected. 
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MAO-A activity and serotonin content in rat brain. Similar 
action on serotonin level was found for all other tested ana- 
logues. Analogues ID-1 and ID-8 were inactive in relation to 
MAO-A activity. 
It follows from the above results that activity of DSIP is 
sensitive to structural alterations of the molecule. Replacement 
of Trp by Tyr in position 1 of the DSIP molecule together with 
introduction of Pro residue in position 2 (analogue ID-5), con- 
siderably increases the efficiency. Replacement of Ala by Tyr 
in position 6 together with introduction of D-Ala residue in 
position 2 (analogue ID-3) also increases the activity. Rather 
unexpectedly, replacement of Trp by Tyr in position 1 of the 
DSIP molecule together with introduction of D-AIa residue in 
position 2 (analogue ID-8), led to drastic loss of the efficiency. 
Increase of hydrophobicity in position 2 (replacement of Ala 
by DVal, DPhe or DLeu) had no effect on activity (analogues 
ID-4 and ID-13), or resulted in loss of the efficiency (analogue 
ID-1) in comparison with DSIP. It should be noted that the 
analogue ID-5 was found to be active also as antimetastatic and 
antiepileptic agent [9,12]. The changes in activity of tested ana- 
logues might be considered as a consequence of their conforma- 
tional pecularities influencing probably membrane-protective 
action of this amphiphilic endogenous peptide. 
Thus we may conclude that DSIP and its analogues can 
modulate changes in brain mitochondrial MAO-A activity in- 
duced by experimental hypoxia in rats. Established effects are 
presumably associated with membrane-protective properties of 
DSIP and some its analogues. These findings may contribute 
to studies on undirect DSIP actions under stress. The problem 
of how this peptide facilitates resistance of animals to stress 
conditions requires further investigation. 
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